Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$22.67 - $28.01 $6,801 - $8,403
-300 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.78 - $29.53 $977 - $2,953
100 Added 50.0%
300 $4,000
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $2,093 - $3,510
100 Added 100.0%
200 $5,000
Q3 2019

Nov 12, 2019

SELL
$22.08 - $47.08 $4,416 - $9,416
-200 Reduced 66.67%
100 $3,000
Q4 2018

Feb 14, 2019

SELL
$27.23 - $45.56 $2,723 - $4,556
-100 Reduced 25.0%
300 $9,000
Q3 2018

Nov 07, 2018

BUY
$37.57 - $50.34 $3,757 - $5,034
100 Added 33.33%
400 $18,000
Q1 2018

May 23, 2018

BUY
$28.83 - $41.01 $8,649 - $12,303
300 New
300 $9,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.